119 related articles for article (PubMed ID: 36871636)
61. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
62. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
63. Decreased expression of microRNA-320a promotes proliferation and invasion of non-small cell lung cancer cells by increasing VDAC1 expression.
Zhang G; Jiang G; Wang C; Zhong K; Zhang J; Xue Q; Li X; Jin H; Li B
Oncotarget; 2016 Aug; 7(31):49470-49480. PubMed ID: 27304056
[TBL] [Abstract][Full Text] [Related]
64. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
65. MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner.
Zhao X; Sun S; Xu J; Luo Y; Xin Y; Wang Y
Oncol Rep; 2018 Aug; 40(2):767-774. PubMed ID: 29845282
[TBL] [Abstract][Full Text] [Related]
66. Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer.
Grills C; Jithesh PV; Blayney J; Zhang SD; Fennell DA
PLoS One; 2011 Jan; 6(1):e14635. PubMed ID: 21297950
[TBL] [Abstract][Full Text] [Related]
67. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
Keinan N; Pahima H; Ben-Hail D; Shoshan-Barmatz V
Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
[TBL] [Abstract][Full Text] [Related]
68. Anti-proliferative activity of biochanin A in human osteosarcoma cells via mitochondrial-involved apoptosis.
Hsu YN; Shyu HW; Hu TW; Yeh JP; Lin YW; Lee LY; Yeh YT; Dai HY; Perng DS; Su SH; Huang YH; Su SJ
Food Chem Toxicol; 2018 Feb; 112():194-204. PubMed ID: 29305928
[TBL] [Abstract][Full Text] [Related]
69. Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration.
Han LP; Wang CP; Han SL
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():81-86. PubMed ID: 30403180
[TBL] [Abstract][Full Text] [Related]
70. VDAC1 Conversely Correlates with Cytc Expression and Predicts Poor Prognosis in Human Breast Cancer Patients.
Chen F; Yin S; Luo B; Wu X; Yan H; Yan D; Chen C; Guan F; Yuan J
Oxid Med Cell Longev; 2021; 2021():7647139. PubMed ID: 33680287
[TBL] [Abstract][Full Text] [Related]
71. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
Ben-Hail D; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
[TBL] [Abstract][Full Text] [Related]
72. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
[TBL] [Abstract][Full Text] [Related]
73. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.
Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530
[TBL] [Abstract][Full Text] [Related]
74. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
[TBL] [Abstract][Full Text] [Related]
75. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
76. CLEFMA Activates the Extrinsic and Intrinsic Apoptotic Processes through JNK1/2 and p38 Pathways in Human Osteosarcoma Cells.
Yang JS; Lin RC; Hsieh YH; Wu HH; Li GC; Lin YC; Yang SF; Lu KH
Molecules; 2019 Sep; 24(18):. PubMed ID: 31505816
[TBL] [Abstract][Full Text] [Related]
77. DDX10 overexpression predicts worse prognosis in osteosarcoma and its deletion prohibits cell activities modulated by MAPK pathway.
Shi JH; Hao YJ
Biochem Biophys Res Commun; 2019 Mar; 510(4):525-529. PubMed ID: 30738579
[TBL] [Abstract][Full Text] [Related]
78. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
[TBL] [Abstract][Full Text] [Related]
79. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
80. Therapeutic potential of targeting
Tang X; Luo L; Li Y; Wu H; Hu Q; Yue H; He X; Zou J; Min S
Aging (Albany NY); 2020 Dec; 13(1):1212-1235. PubMed ID: 33291071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
